Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1. (Q36742060)

16 August 2017

1 reference

title

Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1. (English)

1 reference

16 August 2017

1 reference

1

Derek LeRoith

1 reference

16 August 2017

Shoshana Yakar

2

1 reference

16 August 2017

publication date

1 March 2007

1 reference

Nature Clinical Practice Endocrinology and Metabolism

16 August 2017

published in

1 reference

16 August 2017

volume

3

1 reference

16 August 2017

issue

3

1 reference

16 August 2017

page(s)

302-310

1 reference

Relationship between lipolysis and cyclic AMP generation mediated by atypical beta-adrenoceptors in rat adipocytes

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

Regional fat distribution by dual-energy X-ray absorptiometry: comparison with anthropometry and application in a clinical trial of growth hormone and exercise.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

Cellular actions of the insulin-like growth factor binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

IGFs and IGFBPs: role in health and disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

Compensatory alterations of insulin signal transduction in liver of growth hormone receptor knockout mice.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

Disruption of growth hormone receptor gene causes diminished pancreatic islet size and increased insulin sensitivity in mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

Pancreatic islet-specific expression of an insulin-like growth factor-I transgene compensates islet cell growth in growth hormone receptor gene-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

Normal growth and development in the absence of hepatic insulin-like growth factor I

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

Recombinant, nonglycosylated human insulin-like growth factor-binding protein-3 (IGFBP-3) is degraded preferentially after administration to type II diabetics, resulting in increased endogenous glycosylated IGFBP-3.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

Insulin resistance in the liver-specific IGF-1 gene-deleted mouse is abrogated by deletion of the acid-labile subunit of the IGF-binding protein-3 complex: relative roles of growth hormone and IGF-1 in insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

Growth hormone receptor antagonist improves insulin resistance in acromegaly

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

Hypoglycemic effect of insulin-like growth factor-1 in mice lacking insulin receptors

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

Insulin-like growth factor-I treatment of growth disorders, diabetes mellitus and insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

Changes in free rather than total insulin-like growth factor-I enhance insulin sensitivity and suppress endogenous peak growth hormone (GH) release following short-term low-dose GH administration in young healthy adults

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

Three years of growth hormone treatment in growth hormone-deficient adults: near normalization of body composition and physical performance

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

Growth hormone and the metabolism of carbohydrate and lipid in adipose tissue

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

Effect of growth hormone on plasma fatty acids

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

Action of Growth Hormone in Adipose Tissue

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

Importance of growth hormone for the induction of hepatic low density lipoprotein receptors

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

GH but not IGF-I or insulin increases lipoprotein lipase activity in muscle tissues of hypophysectomised rats

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

The decisive role of free fatty acids for protein conservation during fasting in humans with and without growth hormone

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

Uncoupling insulin signalling by serine/threonine phosphorylation: a molecular basis for insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

The relative roles of growth hormone and IGF-1 in controlling insulin sensitivity

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

Targeted disruption of the beta 3-adrenergic receptor gene.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

Effects of human growth hormone in men over 60 years old

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

Recombinant human growth hormone, but not insulin-like growth factor-I, enhances central fat loss in postmenopausal women undergoing a diet and exercise program

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

Insulin-like growth factor-I stimulates both cell growth and lipogenesis during differentiation of human mesenchymal stem cells into adipocytes

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

Physical and functional interaction of growth hormone and insulin-like growth factor-I signaling elements

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

Changes in IGF-I receptor and IGF-I mRNA during differentiation of 3T3-L1 preadipocytes

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

Low-dose recombinant human growth hormone as adjuvant therapy to lifestyle modifications in the management of obesity

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity: a 12-month placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

Human growth hormone prevents the protein catabolic side effects of prednisone in humans

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

Are the metabolic effects of GH and IGF-I separable?

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

Insulin sensitivity of protein and glucose metabolism in human forearm skeletal muscle

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

Physiologic hyperinsulinemia stimulates protein synthesis and enhances transport of selected amino acids in human skeletal muscle

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

Use of growth hormone and other anabolic agents in AIDS wasting

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

Effect of growth hormone treatment on the adult height of children with chronic renal failure. German Study Group for Growth Hormone Treatment in Chronic Renal Failure

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

Growth hormone has anabolic effects in glucocorticosteroid-dependent children with inflammatory bowel disease: a pilot study

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

Increased mortality associated with growth hormone treatment in critically ill adults

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

Use of growth hormone and insulin-like growth factor I in catabolism that is induced by negative energy balance

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

Anabolic treatment with GH, IGF-I, or anabolic steroids in patients with HIV-associated wasting

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

Wasting in the acquired immune deficiency syndrome is associated with multiple defects in the serum insulin-like growth factor system

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

Insulin therapy increases low plasma growth hormone binding protein in children with new-onset type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

Importance of raised growth hormone levels in mediating the metabolic derangements of diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

Insulin-like growth factor binding proteins as glucoregulators

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

Insulin-like growth factor I stimulates lipid oxidation, reduces protein oxidation, and enhances insulin sensitivity in humans

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

Metabolic effects of rhIGF-1 in normal human subjects

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

Effects of low-dose recombinant human insulin-like growth factor-I on insulin sensitivity, growth hormone and glucagon levels in young adults with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

Recombinant human insulin-like growth factor I increases insulin sensitivity and improves glycemic control in type II diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

Effects of insulin-like growth factor-I on glucose tolerance, insulin levels, and insulin secretion

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0427

7 January 2021

Identifiers

DOI

10.1038/NCPENDMET0427

1 reference

Dimensions Publication ID

16 August 2017

1046529895

0 references

1 reference